Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

The Canadian Bioceutical CBICF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannab


GREY:CBICF - Post by User

The Canadian Bioceutical > CORRECT ME IF I'M WRONG
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by SBoom75on Oct 18, 2018 11:30am
213 Views
Post# 28827389

RE:RE:CORRECT ME IF I'M WRONG

RE:RE:CORRECT ME IF I'M WRONG

I believe that I am still correct.

They calculated the 30% premium based on the close of Oct 17.  The ratio at close is still .1673

If you recall the Canopy and Hiku take over.  I received the ratio on the date the announced the take over.

Hiku went up far higher than the share value at the announcement.

Read the announcement again.

 

The Agreement provides that MPX shareholders will be entitled to receive 0.1673 common shares of iAnthus for each common share of MPX held (the “Exchange Ratio”),

 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities